Sprint Bioscience AB (publ) logo

Sprint Bioscience AB (publ)

SSE:SPRINT.ST

Overview | Financials
Company Name Sprint Bioscience AB (publ)
Symbol SPRINT.ST
Currency SEK
Price 0.876
Market Cap 61,162,408
Dividend Yield 0%
52-week-range 0.451 - 3.28
Industry Biotechnology
Sector Healthcare
CEO Mr. Mathias Skalmstad
Website https://www.sprintbioscience.com

An error occurred while fetching data.

About Sprint Bioscience AB (publ)

Sprint Bioscience AB (publ) develops pharmaceutical products in the areas of cancer and metabolism in Sweden, Europe, the United States, and Asia. It engages in developing VPS34, a drug candidate for the treatment of various types of cancer; and PETRA01, a drug candidate for the treatment of cancer. The company

Related Stocks

AlzeCure Pharma AB (publ) logo

AlzeCure Pharma AB (publ)

ALZCUR.ST

2.49 SEK

Saniona AB (publ) logo

Saniona AB (publ)

SANION.ST

2.105 SEK

AroCell AB (publ) logo

AroCell AB (publ)

AROC.ST

0.405 SEK

Financials

Numbers are in millions USD

Numbers are in millions USD